These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 746478)
1. Screening for Tay-Sachs disease. Sacks L S Afr Med J; 1978 Dec; 54(27):1120. PubMed ID: 746478 [No Abstract] [Full Text] [Related]
2. Screening for Tay-Sachs disease: a note of caution. Rosner F J Clin Ethics; 1991; 2(4):251-2. PubMed ID: 1804394 [No Abstract] [Full Text] [Related]
3. Determinants of utilization of Tay-Sachs screening. Garber AP; Platt LD; Wang SJ; Jam K; Carlson DE; Rotter JI Obstet Gynecol; 1993 Sep; 82(3):460-3. PubMed ID: 8355954 [TBL] [Abstract][Full Text] [Related]
4. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view. Edelson PJ Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171 [No Abstract] [Full Text] [Related]
5. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued? Zlotogora J; Leventhal A Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764 [TBL] [Abstract][Full Text] [Related]
6. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease]. Peleg L; Gazit E; Goldman B; Akstein E Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957 [No Abstract] [Full Text] [Related]
7. Tay-Sachs disease: Part 2. Model of a fatal, preventable, metabolic, genetic disorder. Hecht F; Anatole P; Szucs SC Ariz Med; 1984 Oct; 41(10):661-5. PubMed ID: 6508567 [No Abstract] [Full Text] [Related]
9. The ovrselling of genetic anxiety. Goodman MJ; Goodman LE Hastings Cent Rep; 1982 Oct; 12(5):20-7. PubMed ID: 7174291 [TBL] [Abstract][Full Text] [Related]
10. Novel mutations, including the second most common in Japan, in the beta-hexosaminidase alpha subunit gene, and a simple screening of Japanese patients with Tay-Sachs disease. Tanaka A; Fujimaru M; Choeh K; Isshiki G J Hum Genet; 1999; 44(2):91-5. PubMed ID: 10083731 [TBL] [Abstract][Full Text] [Related]
13. Artificial insemination by donors: the need for genetic screening: late-infantile GM2-gangliosidosis resulting from this technique. Johnson WG; Schwartz RC; Chutorian AM N Engl J Med; 1981 Mar; 304(13):755-7. PubMed ID: 7464883 [No Abstract] [Full Text] [Related]
15. Screening for reproductive counseling: social, ethical, and medicolegal issues in the Tay-Sachs disease experience. Kaback MM Prog Clin Biol Res; 1982; 103 Pt B():447-59. PubMed ID: 7163239 [No Abstract] [Full Text] [Related]
16. Identification of a patient affected by "Juvenile-chronic" Tay Sachs disease in South Italy. Liguori M; Tagarelli G; Romeo N; BagalĂ A; Spadafora P Neurol Sci; 2016 Nov; 37(11):1883-1885. PubMed ID: 27351546 [No Abstract] [Full Text] [Related]
17. Tay-Sachs disease in persons of French-Canadian heritage in northern New England. Palomaki GE; Williams J; Haddow JE; Natowicz MR Am J Med Genet; 1995 May; 56(4):409-12. PubMed ID: 7604851 [TBL] [Abstract][Full Text] [Related]
18. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960 [TBL] [Abstract][Full Text] [Related]
19. Tay-Sachs disease in South Africa. Kromberg JG S Afr Med J; 1981 Mar; 59(14):476. PubMed ID: 7209729 [No Abstract] [Full Text] [Related]
20. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene. Myerowitz R Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]